昊海生科控股股东被罚；诺和诺德减肥药口服片在美获批

Policy Developments - The National Healthcare Security Administration is soliciting public opinions on the "Traditional Chinese Medicine Decoction Pieces Traceability Code Encoding Rules" to promote a unified traceability system for traditional Chinese medicine [1] - The National Medical Products Administration has released the "Internet Drug and Medical Device Information Service Filing Management Regulations," which will take effect immediately [2] Drug and Device Approvals - YHLO Biotech announced that it has received medical device registration certificates for two products from the Guangdong and Hunan Provincial Medical Products Administration [3] - Lianhuan Pharmaceutical reported that its raw material drug, Levonorgestrel, has passed pre-certification by the World Health Organization, although this will not significantly impact current operating performance [4] Capital Market Activities - Taiji Group plans to publicly transfer 40% of its stake in the subsidiary company Aida through a public listing, with an initial transfer price of 108,000 yuan [5] - Jiangsu Zhiyuan Pharmaceutical has completed nearly 300 million yuan in Pre-IPO financing, led by Innovation Works [6] Industry Developments - Tongxin Medical announced that its fully magnetic levitation artificial heart has completed enrollment of 100 patients in the INNOVATE clinical trial in the U.S. [7][8] - Novo Nordisk plans to launch the oral version of Wegovy in the U.S. in January 2026, marking it as the first oral GLP-1 drug for weight management [9] Public Sentiment - The Zhejiang Provincial Government has dispatched a working group to oversee the follow-up handling of a medical incident involving a child's postoperative death at Ningbo University Women's and Children's Hospital [10] Regulatory Actions - Haohai Biological Technology announced that its controlling shareholder, Jiang Wei, has been fined 14.63 million yuan by the China Securities Regulatory Commission for insider trading, which will not affect the company's daily operations [11]